Nature Reviews Urology: Renal cell carcinoma (RCC) is largely percieved to be radioresistant, owing to the failure of several clinical trials involving fractionated radiotherapy. However, following the availability of new technologies, which enable the delivery of ablative doses of radiation, in fewer fractions, excellent responses have been observed among patients with RCC. In this Review, the authors describe the evidence supporting the use of ablative-dose radiotherapy, either alone, or in combination with other therapies in patients with RCC. http://go.nature.com/2tIAdzI
同時也有10000部Youtube影片,追蹤數超過2,910的網紅コバにゃんチャンネル,也在其Youtube影片中提到,...
radiotherapy dose 在 Calculating Radiation Doses for Tumor Treatment ... - YouTube 的推薦與評價
Central to the planning of radiation therapy for cancer treatment is the calculation of radiation dose delivered to a patient. ... <看更多>